US Bancorp
VIR icon

US Bancorp’s Vir Biotechnology VIR Stock Holding History

US Bancorp’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Hold
1,180
– – ﹤0.01% 3388
2026
Q1 		$10.6K Buy
1,180
+28
+2% +$223 ﹤0.01% 3339
2025
Q4 		$6.95K Buy
1,152
+76
+7% +$453 ﹤0.01% 3439
2025
Q3 		$6.14K Buy
1,076
+770
+252% +$3.94K ﹤0.01% 3472
2025
Q2 		$1.54K Sell
306
-1,231
-80% -$6.6K ﹤0.01% 3904
2025
Q1 		$9.96K Buy
1,537
+996
+184% +$8.86K ﹤0.01% 3435
2024
Q4 		$3.97K Sell
541
-5,919
-92% -$46.7K ﹤0.01% 3706
2024
Q3 		$48.4K Sell
6,460
-1,276
-16% -$11.1K ﹤0.01% 2757
2024
Q2 		$68.8K Sell
7,736
-2,604
-25% -$25K ﹤0.01% 2512
2024
Q1 		$105K Sell
10,340
-1,069
-9% -$10.9K ﹤0.01% 2340
2023
Q4 		$115K Buy
11,409
+9,469
+488% +$86.5K ﹤0.01% 2289
2023
Q3 		$18.2K Buy
1,940
+1,170
+152% +$16.7K ﹤0.01% 2930
2023
Q2 		$18.9K Buy
770
+25
+3% +$628 ﹤0.01% 3004
2023
Q1 		$17.3K Buy
745
+11
+1% +$281 ﹤0.01% 3061
2022
Q4 		$18.6K Buy
734
+184
+33% +$4.51K ﹤0.01% 3030
2022
Q3 		$10K Sell
550
-432
-44% -$11K ﹤0.01% 3379
2022
Q2 		$25K Buy
982
+625
+175% +$14.6K ﹤0.01% 2938
2022
Q1 		$9K Buy
357
+66
+23% +$1.96K ﹤0.01% 3428
2021
Q4 		$12K Sell
291
-124
-30% -$4.86K ﹤0.01% 3366
2021
Q3 		$18K Buy
+415
New +$18K ﹤0.01% 3196
2021
Q1 		– Sell
-1,500
Closed -$40K – 3970
2020
Q4 		$40K Hold
1,500
– – ﹤0.01% 2620
2020
Q3 		$51K Hold
1,500
– – ﹤0.01% 2391
2020
Q2 		$61K Buy
+1,500
New +$50.3K ﹤0.01% 2345

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

US Bancorp's VIR Position: Q2 2026 in Review

US Bancorp held its Vir Biotechnology (VIR) position steady in Q2 2026 at 1,180 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3388.

US Bancorp first reported a position in VIR in Q2 2020 and has held it in 23 quarters since. The position peaked at $115K in Q4 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • US Bancorp held 1,180 shares of Vir Biotechnology worth $12K as of Q2 2026.
  • US Bancorp left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3388 holding.
  • US Bancorp first reported a position in Vir Biotechnology in Q2 2020 and has held it in 23 quarters since.
  • US Bancorp's Vir Biotechnology position peaked at $115K in Q4 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.